Resources
… Antibody-drug conjugates (ADCs) are a class of drugs used in the treatment of different cancers.  Unlike chemotherapy, ADCs are  designed to only target and kill tumour cells.  Structurally, ADCs are complex molecules composed of an antibody linked to …
Resources
… Antibody-drug conjugates (ADCs) are a class of drugs used in the treatment of different cancers. Unlike chemotherapy, ADCs are designed to only target and kill tumour cells. Structurally, ADCs are complex molecules composed of an antibody linked to …
Resources
… a powerful tool for the characterisation of two commercial ADCs, brentuximab vedotin (Adcetris ® ) and trastuzumab … set of methods has been developed to characterise ADCs at the intact, subunit, and peptide level. These … applicable to either or both lysine- and cysteineconjugated ADCs. Herein, determination of the drug load distribution …

BioRN Annual Conference 2024

Events
… teams are here to support your developments of mAbs , ADCs and biotherapeutics . mRNA Expertise mRNA is a new …

PEGS Boston Summit

Events
… antibodies, we can provide full analytical support for your ADCs projects. We offer a wide range of services for all …

Swiss Biotech Day 2025

Events
… development and expertise  in: Biotherapeutics  ( mAbs ,  ADCs ) NCEs ,  oligonucleotides ,  peptides mRNA …

NLS Days 2022

Events
… an expert for the development of NBEs  ( mAbs ,  ADCs ,  proteins ) NCEs ,  oligonucleotides ,  peptides mRNA … Validation of analytical methods as per ICH guidelines Characterisation of ADCs at intact, sub-unit and peptide …